Clinical Trial Update: Contributions to Hypertension With Androgen Deprivation Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether androgen deprivation therapy for prostate cancer contributes to hypertension. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Prostate Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Status: COMPLETED